SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?


To: Exacctnt who wrote (635)10/18/1999 9:24:00 AM
From: Rick Buskey  Respond to of 1298
 
Agree.GENZ is one of the best comp. in this industry--if you have to believe in a comp.in this field,you have to trust the AMGN,CHIR, and GENZ to know the real values of these smaller comp.I trust them.



To: Exacctnt who wrote (635)10/18/1999 4:48:00 PM
From: Charles Tutt  Read Replies (2) | Respond to of 1298
 
In my (admittedly limited) experience, companies don't usually go acquiring with stock when their stock is depressed (as GENZ's seems to be). I can only conclude they want CEGE pretty badly; I think they're getting a good deal -- maybe even too good.

JMHO.



To: Exacctnt who wrote (635)2/8/2000 8:41:00 AM
From: Exacctnt  Read Replies (1) | Respond to of 1298
 
Cell Genesys Obtains Fundamental Patent for Lentiviral Gene Therapy Technology.

biz.yahoo.com

Another Patent granted. Don't know the significance of this, we shall see at the market open.